The DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.
1,25‐Dihydroxyvitamin D3 is a potent inducer of nerve growth factor synthesis
Abstract
1,25‐dihydroxyvitamin D 3(1,25‐(OH)2 D 3), a metabolically active form of vitamin D, is shown to increase in a dose‐dependent manner the cellular pool of NGF mRNA in murine L‐929 fibroblasts cultured in a serum‐free medium. This effect can be detected as early as 3 hours after 1,25‐(OH)2 D 3 addition and persists for at least 28 hours. It is accompanied by an enhancement of the amount of NGF‐protein secreted in the culture medium. Since the proto‐oncogene c‐fos appears involved in the regulation of the NGF gene (Mocchetti et al.: Proceedings of the National Academy of Sciences of the United States of America 86:3871‐895, 1989; Hengerer et at: Proceedings of the National Academy of Sciences of the United States of America 87:3899‐3903, 1990), the effect of 1,25‐(OH)2 D 3 on c‐fos expression was analysed and compared to that elicited by other inducers of the NGF gene, serum (Wion et al: FEBS‐ Letters 189:37‐41, 1985) and phorbol 12‐myristate 13‐acetate (PMA) (Wion et al: FEBS Letters 262:42‐44, 1990). Addition of serum or PMA to L‐929 cells was; rapidly followed by a transient activation of the c‐fos gene. In contrast,c‐fos transcripts remained undetected in the presence of 1,25‐(OH)3 D 3 The failure to find any evidence of c‐fos expression suggests that 1,25‐(OH)2 D 3 could enhance the pool of NGF mRNA by a mechanism independent of the c‐fos pathway. The effective concentration range, as low as 10−10 M raises the possibility that 1,25‐(OH)2 D 3 could represent one of the serum factors that might contribute to the regulation of the NGF gene in vitro and possibly in vivo. This suggests a possible therapeutic interest for 1,25‐(OH)2 D 3 in neurodegenerative diseases.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Gene regulation by steroid hormones
Beato, M. (1989) · Cell · doi:10.1016/0092-8674(89)90237-7 · Cited by 3,383
Cited by
Vitamin D and Human Health: Lessons from Vitamin D Receptor Null Mice
Bouillon, R., Carmeliet, G., Verlinden, L., van Etten, E., Verstuyf, A., Luderer, H. F., Lieben, L., Mathieu, C., & Demay, M. (2008) · Endocrine Reviews · doi:10.1210/er.2008-0004 · Cited by 1,783
Distribution of the vitamin D receptor and 1α-hydroxylase in human brain
Eyles, D. W., Smith, S., Kinobe, R., Hewison, M., & McGrath, J. J. (2005) · Journal of Chemical Neuroanatomy · doi:10.1016/j.jchemneu.2004.08.006 · Cited by 1,444
New clues about vitamin D functions in the nervous system
Garcion, E., Wion-Barbot, N., Montero-Menei, C. N., Berger, F., & Wion, D. (2002) · Trends in Endocrinology & Metabolism · doi:10.1016/s1043-2760(01)00547-1 · Cited by 904
Self-citationEyles, D. W., Burne, T. H. J., & McGrath, J. J. (2013) · Frontiers in Neuroendocrinology · doi:10.1016/j.yfrne.2012.07.001 · Cited by 699
Vitamin d3 and brain development
Eyles, D., Brown, J., Mackay-Sim, A., McGrath, J., & Feron, F. (2003) · Neuroscience · doi:10.1016/s0306-4522(03)00040-x · Cited by 552
Hoogendijk, W. J. G., Lips, P., Dik, M. G., Deeg, D. J. H., Beekman, A. T. F., & Penninx, B. W. J. H. (2008) · Archives of General Psychiatry · doi:10.1001/archpsyc.65.5.508 · Cited by 445
Brown, J., Bianco, J. I., McGrath, J. J., & Eyles, D. W. (2003) · Neuroscience Letters · doi:10.1016/s0304-3940(03)00303-3 · Cited by 377
Vitamin D, a neuro-immunomodulator: Implications for neurodegenerative and autoimmune diseases
Fernandes de Abreu, D. A., Eyles, D., & Féron, F. (2009) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2009.05.023 · Cited by 375
Vitamin D and neurocognitive dysfunction: Preventing “D”ecline?
Buell, J. S., & Dawson-Hughes, B. (2008) · Molecular Aspects of Medicine · doi:10.1016/j.mam.2008.05.001 · Cited by 342
Review: The role of vitamin D in nervous system health and disease
DeLuca, G. C., Kimball, S. M., Kolasinski, J., Ramagopalan, S. V., & Ebers, G. C. (2013) · Neuropathology and Applied Neurobiology · doi:10.1111/nan.12020 · Cited by 326
Developmental Vitamin D3 deficiency alters the adult rat brain
Féron, F., Burne, T. H. J., Brown, J., Smith, E., McGrath, J. J., Mackay-Sim, A., & Eyles, D. W. (2005) · Brain Research Bulletin · doi:10.1016/j.brainresbull.2004.12.007 · Cited by 271
Maternal serum vitamin D levels during pregnancy and offspring neurocognitive development
Whitehouse, A. J. O., Holt, B. J., Serralha, M., Holt, P. G., Kusel, M. M. H., & Hart, P. H. (2012) · Pediatrics · doi:10.1542/peds.2011-2644 · Cited by 259
Vitamin D as a neurosteroid affecting the developing and adult brain
Groves, N. J., McGrath, J. J., & Burne, T. H. J. (2014) · Annual Review of Nutrition · doi:10.1146/annurev-nutr-071813-105557 · Cited by 256
Distribution of 1,25-dihydroxyvitamin D3 receptor immunoreactivity in the rat brain and spinal cord
Prüfer, K., Veenstra, T. D., Jirikowski, G. F., & Kumar, R. (1999) · Journal of Chemical Neuroanatomy · doi:10.1016/s0891-0618(99)00002-2 · Cited by 252
Neveu, I., Naveilhan, P., Jehan, F., Baudet, C., Wion, D., De Luca, H. F., & Brachet, P. (1994) · Molecular Brain Research · doi:10.1016/0169-328x(94)90119-8 · Cited by 241
Self-citationMaternal vitamin D levels and the autism phenotype among offspring
Whitehouse, A. J. O., Holt, B. J., Serralha, M., Holt, P. G., Hart, P. H., & Kusel, M. M. H. (2013) · Journal of Autism and Developmental Disorders · doi:10.1007/s10803-012-1676-8 · Cited by 100
Vitamin D and Neurotrophin Levels and Their Impact on the Symptoms of Schizophrenia
Peitl, V., Silić, A., Orlović, I., Vidrih, B., Crnković, D., & Karlović, D. (2020) · Neuropsychobiology · doi:10.1159/000504577 · Cited by 22
Metadata
- Authors
- Wion, D., Macgrogan, D., Neveu, I., Jehan, F., Houlgatte, R., & Brachet, P.
- Venue
- Journal of Neuroscience Research
- Publisher
- Wiley
- Published
- 1991-01
- Volume
- 28
- Issue
- 1
- Pages
- 110-114
- ISSN
- 0360-4012 (ISSN-L)
- 1097-4547
- OpenAlex
- W2033791744
- Cited by
- 211
- References
- 1
- FWCI
- 6.59
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.